NEWS: FDA APPROVES BIOHAVEN’S NURTEC® ODT (RIMEGEPANT) FOR PREVENTION

NURTEC ODT 75 mg is an oral CGRP antagonist previously approved for acute treatment in all eligible adult patients with migraine, regardless of the number of monthly migraine days. It is now also approved for preventive treatment in adult patients with less than 15 headache days per month. NURTEC can be taken up to once daily as needed to stop migraine attacks or taken every other day to help prevent migraine and reduce the number of monthly migraine days. This approval represents an important advancement in care for the millions of people living with migraine. For the first time, one medication can treat and prevent migraine attacks. We at the Manhattan Center of Headache and Neurology are pleased and excited to offer this new preventative treatment to our patients. Please contact us for evaluation and discussion.